| The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19 C Schultheiß, E Willscher, L Paschold, C Gottschick, B Klee, SS Henkes, ... Cell Reports Medicine 3 (6), 100663, 2022 | 363 | 2022 |
| Next-generation sequencing of T and B cell receptor repertoires from COVID-19 patients showed signatures associated with severity of disease C Schultheiß, L Paschold, D Simnica, M Mohme, E Willscher, ... Immunity 53 (2), 442-455. e4, 2020 | 336 | 2020 |
| HLA class I–associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children RA Porritt, L Paschold, MN Rivas, MH Cheng, LM Yonker, H Chandnani, ... The Journal of Clinical Investigation 131 (10), 2021 | 196 | 2021 |
| Clonal expansion and activation of tissue-resident memory-like TH17 cells expressing GM-CSF in the lungs of patients with severe COVID-19 Y Zhao, C Kilian, JE Turner, L Bosurgi, K Roedl, P Bartsch, AC Gnirck, ... Science Immunology 6 (56), eabf6692, 2021 | 169 | 2021 |
| Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post‐acute sequelae of COVID‐19 C Schultheiß, E Willscher, L Paschold, C Gottschick, B Klee, L Bosurgi, ... Journal of Medical Virology 95 (1), e28364, 2023 | 64 | 2023 |
| Efficacy of Ipilimumab vs FOLFOX in combination with Nivolumab and Trastuzumab in patients with previously untreated ERBB2-positive esophagogastric adenocarcinoma: The AIO … A Stein, L Paschold, J Tintelnot, E Goekkurt, SS Henkes, D Simnica, ... JAMA oncology 8 (8), 1150-1158, 2022 | 60 | 2022 |
| Next‐generation immunosequencing reveals pathological T‐cell architecture in autoimmune hepatitis C Schultheiß, D Simnica, E Willscher, A Oberle, L Fanchi, N Bonzanni, ... Hepatology 73 (4), 1436-1448, 2021 | 43 | 2021 |
| PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer A Stein, D Simnica, C Schultheiß, R Scholz, J Tintelnot, E Gökkurt, ... Journal for Immunotherapy of Cancer 9 (7), 2021 | 42 | 2021 |
| Nanobody targeting of epidermal growth factor receptor (EGFR) ectodomain variants overcomes resistance to therapeutic EGFR antibodies J Tintelnot, N Baum, C Schultheiß, F Braig, M Trentmann, J Finter, ... Molecular Cancer Therapeutics 18 (4), 823-833, 2019 | 30 | 2019 |
| Detection of SARS-CoV-2 derived small RNAs and changes in circulating small RNAs associated with COVID-19 C Grehl, C Schultheiss, K Hoffmann, M Binder, T Altmann, I Grosse, ... Viruses 13 (8), 1593, 2021 | 29 | 2021 |
| SLAMF receptors negatively regulate B cell receptor signaling in chronic lymphocytic leukemia via recruitment of prohibitin-2 L von Wenserski, C Schultheiß, S Bolz, S Schliffke, D Simnica, E Willscher, ... Leukemia 35 (4), 1073-1086, 2021 | 29 | 2021 |
| Maturation trajectories and transcriptional landscape of plasmablasts and autoreactive B cells in COVID-19 C Schultheiß, L Paschold, E Willscher, D Simnica, A Wöstemeier, ... Iscience 24 (11), 2021 | 28 | 2021 |
| SARS-CoV-2–specific antibody rearrangements in prepandemic immune repertoires of risk cohorts and patients with COVID-19 L Paschold, D Simnica, E Willscher, MJGT Vehreschild, J Dutzmann, ... The Journal of clinical investigation 131 (1), 2021 | 28 | 2021 |
| From online data collection to identification of disease mechanisms: The IL-1beta, IL-6 and TNF-alpha; cytokine triad is associated with post-acute sequelae of COVID-19 in a … C Schultheiß, E Willscher, L Paschold, C Gottschick, B Klee, SS Henkes, ... MedRxiv, 2021 | 28 | 2021 |
| High-throughput immunogenetics reveals a lack of physiological T cell clusters in patients with autoimmune cytopenias D Simnica, S Schliffke, C Schultheiß, N Bonzanni, LF Fanchi, N Akyüz, ... Frontiers in Immunology 10, 1897, 2019 | 26 | 2019 |
| B cells in autoimmune hepatitis: bystanders or central players? C Schultheiß, S Steinmann, AW Lohse, M Binder Seminars in Immunopathology 44 (4), 411-427, 2022 | 20 | 2022 |
| Identification of a unique TCR repertoire, consistent with a superantigen selection process in Children with Multi-system Inflammatory Syndrome RA Porritt, L Paschold, MN Rivas, MH Cheng, LM Yonker, H Chandnani, ... bioRxiv, 2020 | 20 | 2020 |
| Landscape of T‐cell repertoires with public COVID‐19‐associated T‐cell receptors in pre‐pandemic risk cohorts D Simnica, C Schultheiß, M Mohme, L Paschold, E Willscher, A Fitzek, ... Clinical & Translational Immunology 10 (9), e1340, 2021 | 19 | 2021 |
| Translational analysis and final efficacy of the AVETUX trial–Avelumab, cetuximab and FOLFOX in metastatic colorectal cancer J Tintelnot, I Ristow, M Sauer, D Simnica, C Schultheiß, R Scholz, ... Frontiers in Oncology 12, 993611, 2022 | 18 | 2022 |
| Rapid hypermutation B cell trajectory recruits previously primed B cells upon third SARS-CoV-2 mRNA vaccination L Paschold, B Klee, C Gottschick, E Willscher, S Diexer, C Schultheiß, ... Frontiers in Immunology 13, 2022 | 15 | 2022 |
Mascha BinderAdresse e-mail validée de uk-halle.de
